Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
68.78 USD | +0.42% | +1.68% | +9.51% |
Mar. 21 | Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing | MT |
Mar. 12 | Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.51% | 7.43B | |
+2.69% | 108B | |
+9.38% | 104B | |
+6.58% | 23.66B | |
-12.18% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-12.97% | 16.19B | |
+4.05% | 13.72B | |
+33.28% | 12.22B |
- Stock
- Equities
- Stock Vaxcyte, Inc. - Nasdaq
- News Vaxcyte, Inc.
- Vaxcyte Prices Offering of Common Shares, Warrants; Expects $100 Million Gross Proceeds